Xylocaine
Chronic Subdural Hematoma
University Hospital, CaenN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Chronic Subdural Hematoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tranexamic Acid St. Olavs Hospital | Phase 3 | BB |
Topamax Université de Sherbrooke | Phase 4 | BB |
Acetylsalicylic Acid Tao Liu | Phase 4 | BB |
Keppra Université de Sherbrooke | Phase 4 | BB |
Lipitor Huashan Hospital | Phase 3 | BB |
View all 18 →
Same molecule, other indications
Xylocaine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →